Update of #IP9ATLAS presented by Archana Gopalakrishnan at #AUA25 🇺🇸

This pivotal RCT will evaluate MRI-based surveillance for patients with GG1-2 cancer starting active surveillance

Recruitment is open across the UK!

Next is Dr Archana Gopalakrishnan discussing the #IP9ATLAS trial

For active surveillance, is regular MRI superior to standard care for detecting progression? Recruitment is open and the trial will randomise 1263 patients in 30 centres. Watch this space! #EAU25 🇪🇸

It’s a big first day at #EAU25 for our clinical trials & PhD fellows! 🚀

Come along at 15:15 to ‘On the horizon: Ongoing trials in urology’ in Green Area Retiro

@nikhilmayor.bsky.social presenting #IP7PACIFIC
@ajwlight.bsky.social presenting #IP8FLUORESCE
Archana Gopalakrishnan presenting #IP9ATLAS

🏃 Flying start to #IP9ATLAS - first 5️⃣0️⃣ patients recruited!

🔎 Comparing regular MRI scans to standard of care in patients with prostate cancer on active surveillance

🎉 Thank you to our site teams Imperial College Healthcare NHST, Dartford and Gravesham NHST & Frimley Health NHSFT